Trials / Sponsors / Perspective Therapeutics
Perspective Therapeutics
Industry · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Lead-212 PSV359 Therapy for Patients With Solid Tumors Pancreatic Ductal Adenocarcinoma, Gastric Cancer, Esophageal Cancer | Phase 1 / Phase 2 | 2025-04-28 |
| Recruiting | Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumo Neuroendocrine Tumors Unresectable, Neuroendocrine Tumor Metastatic, Gastroenteropancreatic Neuroendocrine Tumor | Phase 1 / Phase 2 | 2023-09-27 |
| Recruiting | MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Recurrent Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV | Phase 1 / Phase 2 | 2023-06-01 |
| Completed | Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy Melanoma (Skin), Melanoma Stage IV, Melanoma, Uveal | Phase 1 | 2021-03-05 |